GET THE APP

Phytopharmacology and phytotherapy of regulatory T cells: A new approach to treat multiple sclerosis | Abstract
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Abstract

Phytopharmacology and phytotherapy of regulatory T cells: A new approach to treat multiple sclerosis

Author(s): Mohammad Reza Mahmoudian Sani1, Majid Asadi-Samani2, Hojjat Rouhi-Boroujeni*2 and Mehdi Banitalebi-Dehkordi

Multiple sclerosis (MS) is a disorder of central nervous system characterized by demyelination, inflammation, and axonal injury. Regulatory T cells (Tregs) have been defined as CD4+CD25+FoxP3+ T-cells that play a critical role in maintaining self-tolerance and preventing autoimmune diseases. Dysfunction and decreased numbers of Tregs may lead to MS. Web of Science and PubMed databases were searched using the Endnote software for the publications about the role of Tregs in MS published from 2000 to February 2016. The medicinal plants and their derivatives, including Hypericum perforatum, Astragalus membranaceus, Pterodon emarginatus Vogel, curcumin, resveratrol, matrine, Bu Shen Yi Sui Capsule, and Hyungbangpaedok-san have been reported to regulate the function of Tregs in MS. The medicinal plants and their derivatives reported in this study might be useful for upregulation of Tregs through suppressing the activation of autoreactive T cells and hence controlling MS. They should be investigated in clinical trials to help to prevent and treat MS.